Ocular Therapeutix, Inc.
OCUL
$9.16
-$0.12-1.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -290.50M | -265.94M | -249.67M | -216.75M | -192.71M |
| Total Depreciation and Amortization | 4.63M | 4.32M | 4.03M | 3.92M | 3.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.53M | 49.02M | 44.91M | 31.20M | 35.10M |
| Change in Net Operating Assets | 3.14M | 7.71M | 10.67M | 5.73M | 8.31M |
| Cash from Operations | -226.21M | -204.88M | -190.06M | -175.90M | -145.46M |
| Capital Expenditure | -14.74M | -12.01M | -9.37M | -3.47M | -2.97M |
| Sale of Property, Plant, and Equipment | 130.00K | 130.00K | 130.00K | 130.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.61M | -11.88M | -9.24M | -3.34M | -2.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 557.83M | 561.72M | 116.86M | 110.68M | 15.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 557.83M | 561.72M | 116.86M | 110.68M | 15.07M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 317.02M | 344.96M | -82.45M | -68.56M | -133.36M |